Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27531737 | 0.89 | — | — | |
| SCHEMBL14313898 | 0.86 | MEN1 (0.58) | MEN1KMT2A | |
| SCHEMBL945788 | 0.86 | MEN1 (0.58) | MEN1KMT2A | |
| SCHEMBL15802995 | 0.86 | TSHR (0.40) | — | |
| SCHEMBL24297562 | 0.86 | — | — | |
| SCHEMBL15805611 | 0.86 | MEN1 (0.58) | MEN1KMT2A | |
| SCHEMBL14313854 | 0.86 | CA2 (0.33) | — | |
| SCHEMBL14313866 | 0.86 | CA2 (0.33) | — | |
| SCHEMBL2359519 | 0.86 | — | — | |
| SCHEMBL14313911 | 0.86 | MEN1 (0.58) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12023323-B2 | Carbohydrate-binding small molecules with antiviral activity | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2024-07-02 | — | — | US | disclosed |
| US-11091468-B2 | Carbohydrate-binding small molecules with antiviral activity | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2021-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12023323-B2 | Carbohydrate-binding small molecules with antiviral activity | HAVCR2, GALE, ZC3HAV1 | MEN1 3909/4885KMT2A 3593/4885 |
| US-11091468-B2 | Carbohydrate-binding small molecules with antiviral activity | GALE, FUT6, FUT5 | MEN1 3571/4885KMT2A 3465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.